Radiotherapeutic and companion imaging agents to target MC1R
US11406723B2 · kind B2 · utility
0Cited by
12References
12Claims
0Family size
Inventors
Key dates
| Filing date | Sep 18, 2019 |
| Grant date | Aug 9, 2022 |
| Priority date | — |
| Expiry date | Sep 18, 2039 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject matter disclosed herein relates generally to cancer therapy and to anti-cancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target MC1R and their use in the treatment of cancer. Methods of screening for MC1R targeted agents are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.